A Novel Class of Complement 3a Receptor Agonists and Antagonists Derived from the TLQP-21 Peptide
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The complement 3a receptor (C3aR) is a G-protein-coupled receptor (GPCR) involved in inflammatory, metabolic, and neurological diseases. Two endogenous ligands (C3a and TLQP-21) and small molecules (SB290157 and JR14a) differentially signal at C3aR, but these properties are not fully understood and need to be optimized with medicinal chemistry. Here, we generated rationally designed peptidergic analogues of TLQP-21 in an effort to extend the range of compounds with therapeutic potential beyond C3a-derived peptidergic agonists or small-molecule antagonists. We identified key arginines in the central portion of the peptide and the C-terminus, where mutation confers enhanced plasma stability. Mutations at the C-terminal motif alanine–arginine (-AlaArg), with unnatural amino acids and stereoisomers conferred signaling selectivity, enhanced peptide potency (e.g., DArg10_DAla20), or resulted in a functional antagonist (DArg10_Aib20). Overall, we increased our understanding of the C3aR mechanism of action, expanding and differentiating the range of therapeutic potentials for this GPCR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies implicate C3aR signaling in microglial activation in the context of neurodegeneration, and obesity-related conditions[43,45,48,65].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and dynamics of GPCR signaling complexes
Hilger, D., Masureel, M., & Kobilka, B. K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0011-7 · Cited by 969
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Self-citationHoang Thi, T. T., Pilkington, E. H., Nguyen, D. H., Lee, J. S., Park, K. D., & Truong, N. P. (2020) · Polymers · doi:10.3390/polym12020298 · Cited by 668
Litvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
Cero, C., Vostrikov, V. V., Verardi, R., Severini, C., Gopinath, T., Braun, P. D., Sassano, M. F., Gurney, A., Roth, B. L., Vulchanova, L., et al. (2014) · Structure · doi:10.1016/j.str.2014.10.001 · Cited by 71
Self-citationClearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Self-citation
Research works printed but not linked: 61
- Kobilka, 2007, Protein Coupled Receptor Structure and Activation, Biochim. Biophys. Acta, 1768, 794, 10.1016/j.bbamem.2006.10.021 · DOI · Paper page
- Rosenbaum, 2009, The Structure and Function of G-Protein-Coupled Receptors, Nature, 459, 356, 10.1038/nature08144 · DOI · Paper page
- Hauser, 2017, Trends in GPCR Drug Discovery: New Agents, Targets and Indications, Nat. Rev. Drug Discov, 16, 829, 10.1038/nrd.2017.178 · DOI · Paper page
- Lagerström, 2008, Structural Diversity of G Protein-Coupled Receptors and Significance for Drug Discovery, Nat. Rev. Drug Discov., 7, 339, 10.1038/nrd2518 · DOI · Paper page
- Sahu, 2021, The Molecular Identity of the TLQP-21 Peptide Receptor, Cell. Mol. Life Sci., 78, 7133, 10.1007/s00018-021-03944-1 · DOI · Paper page
- Sarma, 2011, The Complement System, Cell Tissue Res., 343, 227, 10.1007/s00441-010-1034-0 · DOI · Paper page
- Cero, 2017, The Neuropeptide TLQP-21 Opposes Obesity via C3aR1-Mediated Enhancement of Adrenergic-Induced Lipolysis, Mol. Metabol., 6, 148, 10.1016/j.molmet.2016.10.005 · DOI · Paper page
- Stephens, 2012, A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · DOI · Paper page
- Brust, 2015, Gαi/o-Coupled Receptor-Mediated Sensitization of Adenylyl Cyclase: 40 Years Later, Eur. J. Pharmacol., 763, 223, 10.1016/j.ejphar.2015.05.014 · DOI
- Sahu, 2019, Peptide/Receptor Co-Evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21, Cell Rep., 28, 2567, 10.1016/j.celrep.2019.07.101 · DOI · Paper page
- Pasupuleti, 2007, Preservation of Antimicrobial Properties of Complement Peptide C3a, from Invertebrates to Humans, J. Biol. Chem., 282, 2520, 10.1074/jbc.M607848200 · DOI
- Quell, 2017, Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse, J. Immunol., 199, 688, 10.4049/jimmunol.1700318 · DOI · Paper page
- Reid, 2013, Downsizing a Human Inflammatory Protein to a Small Molecule with Equal Potency and Functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · DOI
- Rizzi, 2008, The VGF-Derived Peptide TLQP-21: A New Modulatory Peptide for Inflammatory Pain, Neurosci. Lett., 441, 129, 10.1016/j.neulet.2008.06.018 · DOI
- Koc, 2021, Changes in VGF and C3aR1 Gene Expression in Human Adipose Tissue in Obesity, Mol. Biol. Rep., 48, 251, 10.1007/s11033-020-06043-9 · DOI · Paper page
- Bartolomucci, 2006, TLQP-21, a VGF-Derived Peptide, Increases Energy Expenditure and Prevents the Early Phase of Diet-Induced Obesity, Proc. Natl. Acad. Sci. U. S. A., 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Possenti, 2012, Characterization of a Novel Peripheral Pro-Lipolytic Mechanism in Mice: Role of VGF-Derived Peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · DOI · Paper page
- Rodriguez, 2024, Functional Profiling of the G Protein-Coupled Receptor C3aR1 Reveals Ligand-Mediated Biased Agonism, J. Biol. Chem., 300, 105549, 10.1016/j.jbc.2023.105549 · DOI · Paper page
- Gao, 2020, The Complement C3a and C3a Receptor Pathway in Kidney Diseases, Front. Immunol., 11, 1875, 10.3389/fimmu.2020.01875 · DOI
- Hugli, 1977, Synthetic Peptides with the Biological Activities and Specificity of Human C3a Anaphylatoxin, Proc. Natl. Acad. Sci. U. S. A., 74, 1826, 10.1073/pnas.74.5.1826 · DOI · Paper page
- Morganroth, 1990, C3a57–77, a C-Terminal Peptide, Causes Thromboxane-Dependent Pulmonary Vascular Constriction in Isolated Perfused Rat Lungs, Am. Rev. Respir. Dis., 141, 296, 10.1164/ajrccm/141.2.296 · DOI
- Scully, 2010, Selective Hexapeptide Agonists and Antagonists for Human Complement C3a Receptor, J. Med. Chem., 53, 4938, 10.1021/jm1003705 · doi:10.1021/jm1003705
- Denonne, 2007, Discovery of New C3aR Ligands. Part 2: Amino-Piperidine Derivatives, Bioorg. Med. Chem. Lett., 17, 3262, 10.1016/j.bmcl.2007.04.023 · doi:10.1016/j.bmcl.2007.04.023
- Reid, 2014, Potent Heterocyclic Ligands for Human Complement C3a Receptor, J. Med. Chem., 57, 8459, 10.1021/jm500956p · DOI
- Ames, 2001, Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models, J. Immunol., 166, 6341, 10.4049/jimmunol.166.10.6341 · DOI · Paper page
- Rowley, 2020, Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity, J. Med. Chem., 63, 529, 10.1021/acs.jmedchem.9b00927 · DOI
- Alexander, 2021, THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G Protein-Coupled Receptors, Br. J. Pharmacol., 178, S27, 10.1111/bph.15538 · DOI · Paper page
- Mathieu, 2005, The C3a Receptor Antagonist SB 290157 Has Agonist Activity, Immunol. Lett., 100, 139, 10.1016/j.imlet.2005.03.003 · DOI
- Luo, 2025, Structural Insights into the Agonist Activity of the Nonpeptide Modulator JR14a on C3aR, Cell Discov., 11, 7, 10.1038/s41421-024-00765-x · DOI
- Masin, 2015, 6─Bordetella Protein Toxins, 161, 10.1016/B978-0-12-800188-2.00006-9 · DOI
- Mangmool, 2011, Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX), Toxins, 3, 884, 10.3390/toxins3070884 · DOI · Paper page
- Leaney, 2000, The Role of Members of the Pertussis Toxin-Sensitive Family of G Proteins in Coupling Receptors to the Activation of the G Protein-Gated Inwardly Rectifying Potassium Channel, Proc. Natl. Acad. Sci. U. S. A., 97, 5651, 10.1073/pnas.080572297 · DOI
- Beautrait, 2017, A New Inhibitor of the β-Arrestin/AP2 Endocytic Complex Reveals Interplay between GPCR Internalization and Signalling, Nat. Commun., 8, 15054, 10.1038/ncomms15054 · DOI · Paper page
- Sundqvist, 2020, Barbadin Selectively Modulates FPR2-Mediated Neutrophil Functions Independent of Receptor Endocytosis, Biochim. Biophys. Acta, Mol. Cell Res., 1867, 118849, 10.1016/j.bbamcr.2020.118849 · DOI
- He, 2021, Barbadin Potentiates Long-Term Effects of Lorcaserin on POMC Neurons and Weight Loss, J. Neurosci., 41, 5734, 10.1523/JNEUROSCI.3210-20.2021 · DOI
- Roberts, 2009, Metabolic Phenotyping of a Model of Adipocyte Differentiation, Physiol. Genomics, 39, 109, 10.1152/physiolgenomics.90365.2008 · DOI
- Malina, 2005, Conjugation of Fatty Acids with Different Lengths Modulates the Antibacterial and Antifungal Activity of a Cationic Biologically Inactive Peptide, Biochem. J., 390, 695, 10.1042/BJ20050520 · DOI · Paper page
- Storck, 2020, Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19–4LF), Antibiotics (Basel), 9, 844, 10.3390/antibiotics9120844 · doi:10.3390/antibiotics9120844
- Polyethylene Glycol─an overview|ScienceDirect Topics. https://www.sciencedirect.com/topics/neuroscience/polyethylene-glycol (accessed June 06, 2023).
- Suk, 2016, PEGylation as a Strategy for Improving Nanoparticle-Based Drug and Gene Delivery, Adv. Drug Deliv. Rev., 99, 28, 10.1016/j.addr.2015.09.012 · DOI · Paper page
- Chao, 1999, Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function, J. Biol. Chem., 274, 9721, 10.1074/jbc.274.14.9721 · DOI · Paper page
- Li, 2021, The “C3aR Antagonist” SB290157 Is a Partial C5aR2 Agonist, Front. Pharmacol., 11, 591398, 10.3389/fphar.2020.591398 · DOI
- Wang, 2023, Revealing the Signaling of Complement Receptors C3aR and C5aR1 by Anaphylatoxins, Nat. Chem. Biol., 19, 1351, 10.1038/s41589-023-01339-w · DOI
- Doolen, 2017, Complement 3a Receptor in Dorsal Horn Microglia Mediates Pronociceptive Neuropeptide Signaling, Glia, 65, 1976, 10.1002/glia.23208 · DOI · Paper page
- Cho, 2020, TLQP-21 Mediated Activation of Microglial BV2 Cells Promotes Clearance of Extracellular Fibril Amyloid-β, Biochem. Biophys. Res. Commun., 524, 764, 10.1016/j.bbrc.2020.01.111 · DOI
- Rivolta, 2017, JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells, Front. Cell. Neurosci., 11, 41, 10.3389/fncel.2017.00041 · DOI
- Coulthard, 2015, Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-Evaluating the Evidence and the Myth, J. Immunol., 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
- Reid, 2013, Downsizing a Human Inflammatory Protein to a Small Molecule with Equal Potency and Functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · DOI
- Klos, 2013, International Union of Basic and Clinical Pharmacology. [Corrected]. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
- Li, 2008, Cyclic AMP Plays a Critical Role in C3a-Receptor Mediated Regulation of Dendritic Cells in Antigen Uptake and T-Cell Stimulation, Blood, 112, 5084, 10.1182/blood-2008-05-156646 · DOI · Paper page
- Stephens, 2012, A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · DOI · Paper page
- Fargali, 2014, The Granin VGF Promotes Genesis of Secretory Vesicles, and Regulates Circulating Catecholamine Levels and Blood Pressure, FASEB J., 28, 2120, 10.1096/fj.13-239509 · DOI · Paper page
- El Gaamouch, 2020, VGF-Derived Peptide TLQP-21 Modulates Microglial Function through C3aR1 Signaling Pathways and Reduces Neuropathology in 5xFAD Mice, Mol. Neurodegener., 15, 4, 10.1186/s13024-020-0357-x · DOI · Paper page
- Ahmad, 2022, Abstract 15: The Novel Complement C3ar Antagonist Jr14a Is Neuroprotective In Stroke, Stroke, 53, A15, 10.1161/str.53.suppl_1.15 · DOI
- Ahmad, 2020, C3a Receptor Antagonist Therapy Is Protective with or without Thrombolysis in Murine Thromboembolic Stroke, Br. J. Pharmacol., 177, 2466, 10.1111/bph.14989 · DOI
- Ahmad, 2019, C3a Receptor Inhibition Protects Brain Endothelial Cells Against Oxygen-Glucose Deprivation/Reperfusion, Exp. Neurobiol., 28, 216, 10.5607/en.2019.28.2.216 · DOI
- Ishii, 2021, Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism, Front. Immunol., 12, 628062, 10.3389/fimmu.2021.628062 · DOI
- Vibhuti, 2011, Distinct and Shared Roles of β-Arrestin-1 and β-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells, PLoS One, 6, 10.1371/journal.pone.0019585 · doi:10.1371/journal.pone.0019585
- Yadav, 2023, Molecular Basis of Anaphylatoxin Binding, Activation, and Signaling Bias at Complement Receptors, Cell, 186, 4956, 10.1016/j.cell.2023.09.020 · DOI
- Kim, 2025, Structural Insights into Small-Molecule Agonist Recognition and Activation of Complement Receptor C3aR, EMBO J., 44, 2803, 10.1038/s44318-025-00429-w · DOI
- Blasi, 1990, Immortalization of Murine Microglial Cells by a V-Raf/v-Myc Carrying Retrovirus, J. Neuroimmunol, 27, 229, 10.1016/0165-5728(90)90073-V · DOI · Paper page
Cited by
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Self-citation
Metadata
- Authors
- Rodriguez, P., Pallais, J. P., He, R., Razzoli, M., McKee, J. L., Bock, H. A., McCorvy, J. D., Sham, Y. Y., DiMarchi, R., & Bartolomucci, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2025-09-03
- Volume
- 68
- Issue
- 18
- Pages
- 19107-19121
- ISSN
- 0022-2623
- 1520-4804
- Cited by
- 5
- References
- 7
- Language
- en
- Funders
- National Institute of Mental Health (75N95023C00021)
- National Institute of General Medical Sciences (R35 GM133421)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK083250)
- Clinical and Translational Science Institute, University of Minnesota (NA)
- Institute for Diabetes, Obesity and Metabolism, University of Minnesota (NA)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.